The FDA has approved Evarrest fibrin sealant patch, from Ethicon Biosurgery, a product that rapidly aids in stopping problematic bleeding...
The FDA has approved an additional indication for Ethicon's Evarrest (fibrin sealant patch), as an adjunct to hemostasis for control...
Ethicon has announced new data from a global cardiovascular (CV) Phase III clinical trial of the Evarrest Fibrin Sealant Patch....
Ethicon announced that the U.S. FDA has approved an expanded indication for Evarrest Fibrin Sealant Patch, which leverages biologics to...
On 27 June 2013, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting...
The FDA has approved an expanded indication for Evarrest Fibrin Sealant Patch, from Ethicon, which leverages biologics to rapidly and...